Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations.
about
Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals.Immunoglobulin A, G, and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 L1 after newly acquired infection.Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women.Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sitesSeroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica.Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa RicaAssociation of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women.Trends of cervical cancer in Greenland: a 60-year overview.Human papillomavirus seropositivity and risks of head and neck cancer.Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.Seroresponses to virus-like particles of human papillomavirus types 16, 18, 31, 33, and 45 in San people of Southern Africa.Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles.
P2860
Q34995733-643D3081-F98C-45F3-9DB1-1E1207285611Q35562265-75F8F3D3-4320-416F-B85A-2FB81C704CF3Q36452565-B5F6A5D7-FB3C-4EEE-B8BB-62DF0E3104EAQ36646726-EB7693C9-2DF8-461B-9D9F-0B657168CC79Q36671130-264D2328-105E-4020-8E88-20BDB9BD62A1Q36695693-A712215B-8A50-4497-B223-33482A5E05EEQ36921606-F69D84A9-E0AA-49B4-AD68-464D6DB3C49DQ38186781-8A5CC16A-EC52-41D1-943F-490EEA0A344FQ44212964-ADE875EF-A0CB-477E-B172-7DB3A1555A29Q45744233-9E6F1C92-D4E9-4E28-A917-51456CB41639Q45745124-EA07C49E-4C6A-4F97-9CD2-C6F4C3752CC2Q45748191-7B49159C-B976-46A9-A10F-E79D7B6F7AB3
P2860
Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Seroreactivity to HPV16 virus- ...... risk in high-risk populations.
@en
Seroreactivity to HPV16 virus- ...... risk in high-risk populations.
@nl
type
label
Seroreactivity to HPV16 virus- ...... risk in high-risk populations.
@en
Seroreactivity to HPV16 virus- ...... risk in high-risk populations.
@nl
prefLabel
Seroreactivity to HPV16 virus- ...... risk in high-risk populations.
@en
Seroreactivity to HPV16 virus- ...... risk in high-risk populations.
@nl
P2093
P2860
P1476
Seroreactivity to HPV16 virus- ...... risk in high-risk populations.
@en
P2093
A J van den Brule
B Nonnenmacher
J M Walboomers
J T Schiller
N L Hubbert
R Kirnbauer
S Kruger Kjaer
P2860
P304
P356
10.1002/(SICI)1097-0215(19961211)68:6<704::AID-IJC3>3.0.CO;2-7
P577
1996-12-01T00:00:00Z